|Articles|July 25, 2016
ProTrials Research Selected by Calithera Biosciences
ProTrials Research, Inc. and Calithera Biosciences have reached an agreement for early phase clinical trial support.
Advertisement
ProTrials Research, Inc. and Calithera Biosciences have reached an agreement for early phase clinical trial support. ProTrials will provide clinical development services for Calithera’s tumor metabolism product candidate.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer
3
Applied Clinical Trials: October 2025 Interactive Digital Edition
4
Adaptive Trial Design as a Pathway to Faster Development
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
